Dearnaley, D., Syndikus, I., Mossop, H., Birtle, A., Bloomfield, D., Cruickshank, C., Graham, J., Hassan, S., Khoo, V., Logue, J., Mayles, H., Money-Kyrle, J., Naismith, O., Panades, M., Patterson, H., Scrase, C., Staffurth, J., Tremlett, J., Griffin, C., & Hall, E. (n.d.). 8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group. European journal of cancer, 51, S712–. http://access.bl.uk/ark:/81055/vdc_100030687872.0x00005e